Risk factors for invasive pneumococcal disease in a community with a high proportion of non vaccine serotypes.

[1]  W. Ricciardi,et al.  Effectiveness of 7-valent pneumococcal conjugate vaccine: A meta-analysis of post-marketing studies , 2015 .

[2]  C. Muñoz-Almagro,et al.  Clinical Presentation of Invasive Pneumococcal Disease in Spain in the Era of Heptavalent Conjugate Vaccine , 2012, The Pediatric infectious disease journal.

[3]  Montse Morta,et al.  Serotypes and clones causing invasive pneumococcal disease before the use of new conjugate vaccines in Catalonia, Spain. , 2011, The Journal of infection.

[4]  M. Ezzati,et al.  Association of Secondhand Smoke Exposure with Pediatric Invasive Bacterial Disease and Bacterial Carriage: A Systematic Review and Meta-analysis , 2010, PLoS medicine.

[5]  W. Schaffner,et al.  Risk Factors for Invasive Pneumococcal Disease in Children in the Era of Conjugate Vaccine Use , 2010, Pediatrics.

[6]  Päivi Heikkilä,et al.  Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies , 2010, PLoS medicine.

[7]  K. Krogfelt,et al.  Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme. , 2010, Vaccine.

[8]  S. Kaplan,et al.  Serotype 19A Is the Most Common Serotype Causing Invasive Pneumococcal Infections in Children , 2010, Pediatrics.

[9]  P. Ciruela,et al.  Changes in serotypes causing invasive pneumococcal disease (2005-2007 vs. 1997-1999) in children under 2 years of age in a population with intermediate coverage of the 7-valent pneumococcal conjugated vaccine. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[10]  M. P. van der Linden,et al.  Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany. , 2009, Vaccine.

[11]  L. Salleras,et al.  Impacto de la vacuna neumocócica conjugada heptavalente en una población con valores bajos-intermedios de vacunación , 2009 .

[12]  J. Lynch,et al.  Streptococcus pneumoniae: Epidemiology, Risk Factors, and Strategies for Prevention , 2009, Seminars in respiratory and critical care medicine.

[13]  I. Aaberge.  Experience with pneumococcal conjugate vaccine in Norway , 2009, Expert review of vaccines.

[14]  C. Muñoz-Almagro,et al.  Identification of pneumococcal serotypes from culture-negative clinical specimens by novel real-time PCR. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[15]  D. Levy-bruhl,et al.  Impact of infant pneumococcal vaccination on invasive pneumococcal diseases in France, 2001-2006. , 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[16]  C. Byington,et al.  Seasonal Invasive Pneumococcal Disease in Children: Role of Preceding Respiratory Viral Infection , 2008, Pediatrics.

[17]  D. Caugant,et al.  Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway. , 2008, Vaccine.

[18]  C. Byington,et al.  Risk factors for pediatric invasive pneumococcal disease in the Intermountain West, 1996-2002. , 2008, Annals of epidemiology.

[19]  C. Muñoz-Almagro,et al.  Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  R. Biggar,et al.  Perinatal and crowding-related risk factors for invasive pneumococcal disease in infants and young children: a population-based case-control study. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  I. Pereiró,et al.  Risk factors for invasive disease among children in Spain. , 2004, The Journal of infection.

[22]  R. Dagan,et al.  Vaccination of day-care center attendees reduces carriage of Streptococcus pneumoniae among their younger siblings , 2003, The Pediatric infectious disease journal.

[23]  A. Schuchat,et al.  Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. , 2003, The New England journal of medicine.

[24]  I. Jado,et al.  Dot blot assay for the serotyping of pneumococci , 1997, Journal of clinical microbiology.

[25]  B. Greenwood,et al.  A study of risk factors for pneumococcal disease among children in a rural area of west Africa. , 1996, International journal of epidemiology.

[26]  J. Eskola,et al.  Risk factors for primary invasive pneumococcal disease among children in Finland. , 1995, JAMA.

[27]  B. Gessner,et al.  Risk factors for invasive disease caused by Streptococcus pneumoniae among Alaska native children younger than two years of age. , 1995, The Pediatric infectious disease journal.

[28]  Henry Nider,et al.  Report of the Committee on Infectious Diseases , 1989 .

[29]  D. Musher,et al.  Bacterial adherence to pharyngeal cells during viral infection. , 1980, The Journal of infectious diseases.

[30]  F. González Martínez,et al.  [Emergence of invasive pneumococcal disease caused by non-vaccine serotypes in the era of the 7-valent conjugate vaccine]. , 2014, Anales de Pediatría.

[31]  P. Ciruela,et al.  [Impact of 7-valent pneumococcal conjugate vaccination in a population with low to intermediate vaccination levels]. , 2009, Enfermedades infecciosas y microbiologia clinica.

[32]  F. Martinón-Torres,et al.  Calendario vacunal de la Asociación Española de Pediatría: Recomendaciones 2009 , 2009 .

[33]  Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005. , 2008, MMWR. Morbidity and mortality weekly report.

[34]  F. Martinón-Torres,et al.  [Vaccination schedule of the Spanish Association of Pediatrics: recommendations 2007]. , 2007, Anales de pediatria.

[35]  S. Pelton.  Risk factors for invasive pneumococcal disease in children: a population-based case-control study in North America. , 2000, Pediatrics.

[36]  T Nagatake,et al.  Streptococcus pneumoniae , 2020, Methods in Molecular Biology.

[37]  D. Musher,et al.  Association of invasive pneumococcal disease with season, atmospheric conditions, air pollution, and the isolation of respiratory viruses. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[38]  Great Britain. Foreign Office.,et al.  Classification of occupations , 1960 .